Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vandel

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
L'Encephale|July 1, 1985
[Dexamethasone test: suppressors and non-suppressors, what's the difference?]S Vandel, B Bonin, B Vandel, et al.
European Journal of Clinical Pharmacology|January 1, 1982
Biotransformation of amitriptyline in depressive patients: urinary excretion of seven metabolitesB Vandel, M Sandoz, S Vandel, et al.
European Journal of Clinical Pharmacology|January 1, 1982
Relationship between the plasma concentration of clomipramine and desmethylclomipramine in depressive patients and the clinical responseB Vandel, S Vandel, J M Jounet, et al.
L'Encephale|January 1, 1981
[Clomipramine and desmethylclomipramine: relationship between plasma levels and clinical effect (author's transl)]B Vandel, S Vandel, J M Jounet, et al.
Therapie|April 27, 2001
Loxapine side-effects: 3 case reports of hyperleukocytosisE Haffen, P Vandel, S Vandel, et al.
Pharmacopsychiatry|July 1, 1989
Desipramine dose prediction based on 24-hour single-dose levels: feasibility and validityG Bertschy, S Vandel, B Vandel, et al.
Pharmacopsychiatry|November 1, 1990
Desipramine induces cardiac beta-adrenergic sensitivity decrease in major depressed patients without relationship to therapeutic responseG Bertschy, S Vandel, A Puech, et al.
L'Encephale|June 30, 2000
[Extrapyramidal side effects of neuroleptic and antidepressant treatment: assessment of potential risk factors through CYP2D6 genetic polymorphism]K Reggiani, P Vandel, E Haffen, et al.
Therapie|January 1, 1987
[Pharmacokinetic interaction between clomipramine and phenothiazines]S Vandel, M Sandoz, B Vandel, et al.
Neuropsychobiology|January 1, 1989
Cardiac beta-adrenergic sensitivity in depression: relation with endogenous subtype and desipramine responseG Bertschy, S Vandel, A Puech, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
L'Encephale|July 1, 1985
[Dexamethasone test: suppressors and non-suppressors, what's the difference?]S Vandel, B Bonin, B Vandel, et al.
European Journal of Clinical Pharmacology|January 1, 1982
Biotransformation of amitriptyline in depressive patients: urinary excretion of seven metabolitesB Vandel, M Sandoz, S Vandel, et al.
European Journal of Clinical Pharmacology|January 1, 1982
Relationship between the plasma concentration of clomipramine and desmethylclomipramine in depressive patients and the clinical responseB Vandel, S Vandel, J M Jounet, et al.
L'Encephale|January 1, 1981
[Clomipramine and desmethylclomipramine: relationship between plasma levels and clinical effect (author's transl)]B Vandel, S Vandel, J M Jounet, et al.
Therapie|April 27, 2001
Loxapine side-effects: 3 case reports of hyperleukocytosisE Haffen, P Vandel, S Vandel, et al.
Pharmacopsychiatry|July 1, 1989
Desipramine dose prediction based on 24-hour single-dose levels: feasibility and validityG Bertschy, S Vandel, B Vandel, et al.
Pharmacopsychiatry|November 1, 1990
Desipramine induces cardiac beta-adrenergic sensitivity decrease in major depressed patients without relationship to therapeutic responseG Bertschy, S Vandel, A Puech, et al.
L'Encephale|June 30, 2000
[Extrapyramidal side effects of neuroleptic and antidepressant treatment: assessment of potential risk factors through CYP2D6 genetic polymorphism]K Reggiani, P Vandel, E Haffen, et al.
Therapie|January 1, 1987
[Pharmacokinetic interaction between clomipramine and phenothiazines]S Vandel, M Sandoz, B Vandel, et al.
Neuropsychobiology|January 1, 1989
Cardiac beta-adrenergic sensitivity in depression: relation with endogenous subtype and desipramine responseG Bertschy, S Vandel, A Puech, et al.
Pageof 9